drugset / Trial / NCT03286101

Efficacy and Safety of Topical 0.5% Ivermectin Lotion for the Treatment of Head Lice Infestation in Filipinos

NCT03286101

Phase 2 Completed 120 enrolled United Laboratories
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This is a randomized, double-blind, placebo-controlled clinical study evaluating the efficacy and safety of a single application of 0.5% ivermectin lotion in Filipino subjects with head lice.

Timeline

Start
2017-09-14
Primary completion
2017-10-12
Completion
2017-11-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Ivermectin Small molecule 0.5 %